LONDON--(BUSINESS WIRE)--Technavio has announced its newest market research report on the human growth hormone market in the US for the period 2018-2022, providing the latest cutting-edge insights on this popular market.
The report will follow up on Technavio’s previous research report on the human growth hormone market in the US, offering an updated analysis of the market with regards to the current competitive landscape, detailed understanding of the latest trends and drivers, and new insights for the forecast period.
The updated research report on the human growth hormone market in the US is an integral part of Technavio’s cardiovascular and metabolic disorders portfolio. Technavio covers an extensive range of market research reports on cardiovascular and metabolic disorder treatment market, analyzing different regions and top industry segments. Some of the topics covered include inflammatory bowel disease, rheumatoid arthritis drugs, age-related macular degeneration, and diabetic retinopathy.
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
Save more with Technavio. Buy 2 reports and get the third for FREE: View all Technavio’s current offers
Human growth hormone market in the US: market analysis and forecast
Human growth hormone, also known as somatotropin, is a peptide with 191 amino acids and 2 sulfhydryl bridges. It is produced by the anterior pituitary, and it is required to attain normal size for children and adolescents. It also has major effects on lipid and carbohydrate metabolism of an individual.
In the previous report, a senior research analyst at Technavio stated, “Growth hormone deficiency can occur due to damage to the pituitary or the hypothalamus gland, or it can be acquired genetically. Some of the signs of growth hormone deficiency are adiposity, short stature, and hypoglycemia. The effects of human growth hormone are mainly mediated by IGF-1 and IGF-2. There are two forms of recombinant human growth hormone approved in the market: Somatropin and Somatrem.”
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Topics covered in the previous report included the following:
- Childhood-onset growth hormone deficiency
- Adult-onset growth hormone deficiency
- Market drivers
- Market trends
- Market challenges
- Competitive landscape
- And more
Using its previous analysis as a starting point, Technavio’s new report will re-evaluate the market with an eye for new developments in the field of human growth hormones, as well as external factors and new competitors. The cardiovascular and metabolic disorders market is characterized by an increased focus on the development of innovative compounds for new targets to preserve or restore the physiological functions of patients.
|Big savings with Technavio this February!|
Get 20% OFF on all
Education Technology reports. This offer is valid only till the 28th of this month.
Celebrate winter sports with 23% OFF on all reports in the Outdoor Gear library (Offer valid from Feb 9-25).
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at firstname.lastname@example.org.